Market Overview

QuintilesIMS to Announce Fourth-Quarter 2016 Results and Issue 2017 Guidance on February 14, 2017


Quintiles IMS Holdings, Inc. ("QuintilesIMS") (NYSE: Q) will announce its fourth-quarter and full-year 2016 financial results and issue 2017 guidance before the market opens on Tuesday, February 14, 2017. The QuintilesIMS management team will host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the QuintilesIMS Investor Relations website at

Interested parties are invited to listen to the live event and view the presentation slides via webcast on the QuintilesIMS Investor Relations website at The discussion also will be available by dialing +1-800-616-7436 in the U.S. and Canada, or +1-303-223-4394 for international callers.

A replay of the webcast will be available approximately two hours after the conclusion of the live event on February 14. To access the webcast recording, visit

About QuintilesIMS
QuintilesIMS (NYSE: Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS's approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS's broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit


Click here to subscribe to Mobile Alerts for QuintilesIMS.

Quintiles IMS Holdings, Inc.
Investor Relations:
Andrew Markwick, 973-257-7144
Media Relations:
Tor Constantino, 484-567-6732
Phil Bridges, 919-998-1653
Mobile: 919-457-6347

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at